Sunshine Biopharma (SBFM) EBT Margin (2015 - 2026)
Sunshine Biopharma (SBFM) posted EBT Margin of 15.38% for Q1 2026, up 23.87% on a QoQ basis from 20.2% in Q4 2025, and down 167.0% year-over-year from 22.95% in Q1 2025.
Sunshine Biopharma (SBFM) EBT Margin (2015 - 2026) Analysis & Trends
Sunshine Biopharma's EBT Margin history runs 10 years deep, the most recent figure standing at 15.38% for Q1 2026.
- Quarterly EBT Margin fell 167.0% year-over-year to 15.38% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 16.84% (down 214.0% YoY) and the FY2025 annual result came in at 16.4%, down 100.0% from the prior year.
- EBT Margin was 15.38% for Q1 2026 at Sunshine Biopharma, up from 20.2% in the prior quarter.
- Across five years, EBT Margin topped out at 9.01% in Q2 2024 and bottomed at 1097.09% in Q3 2022.
- A 5-year average of 192.29% and a median of 16.73% in 2024 frame the typical range for EBT Margin.
- Peak annual rise in EBT Margin reached 1443245 bps in 2022, while the deepest fall reached 137462 bps in 2022.
- Sunshine Biopharma's EBT Margin stood at 590.86% in 2022, then jumped by 98 bps to 13.41% in 2023, then sank by 78 bps to 23.83% in 2024, then rose by 15 bps to 20.2% in 2025, then increased by 24 bps to 15.38% in 2026.
- Business Quant data shows SBFM's EBT Margin at 15.38% in Q1 2026, 20.2% in Q4 2025, and 10.84% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 91.98 Bn | 90.11 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 10.97% |
| 3 | Zoetis | 32.99 Bn | 31.05 Bn | 1.62 Bn | 33.51% |
| 4 | Takeda Pharmaceutical | 27.75 Bn | 23.69 Bn | 4.39 Bn | -41.57% |
| 5 | United Therapeutics | 23.03 Bn | 20.87 Bn | 648.10 Mn | 40.73% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.51 Bn | 18.70 Bn | 1.16 Bn | -7.05% |
| 8 | Neurocrine Biosciences | 18.10 Bn | 16.78 Bn | 800.70 Mn | 30.30% |
| 9 | Elanco Animal Health | 12.77 Bn | 12.34 Bn | 785.00 Mn | 6.35% |
| 10 | Sunshine Biopharma | 696,643.46 | -6.22 Mn | 2.18 Mn | -15.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.38% |
| Dec 31, 2025 | -20.20% |
| Sep 30, 2025 | -10.84% |
| Jun 30, 2025 | -21.04% |
| Mar 31, 2025 | -13.71% |
| Dec 31, 2024 | -23.83% |
| Sep 30, 2024 | -11.65% |
| Jun 30, 2024 | -9.01% |
| Mar 31, 2024 | -16.73% |
| Dec 31, 2023 | -13.41% |
| Sep 30, 2023 | -10.25% |
| Jun 30, 2023 | -14.65% |
| Mar 31, 2023 | -33.84% |
| Dec 31, 2022 | -590.86% |
| Sep 30, 2022 | -1,097.09% |
| Jun 30, 2022 | -358.51% |
| Mar 31, 2022 | -1,007.98% |
| Dec 31, 2021 | 783.75% |
| Sep 30, 2021 | -8,018.47% |
| Jun 30, 2021 | -5,445.12% |